FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar Disorder in Children
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event. The decision was apparently made on the basis of a few very short term studies populated by a small number of subjects, a decision which is most uncharacteristic of the FDA. I have a number of acquaintances... Read more












